Hysteresis activation of accelerated pacing

• US 6,889,078 B2
• Filed: 04/26/2001
• Issued: 05/03/2005
• Est. Priority Date: 04/26/2001
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Grandjean, Pierre A., Struble, Chester L.
• Primary Examiner(s): Bockelman, Mark
• Application Number:
  US09/842,233
• Publication Number:
  US 20020183793A1
• Time in Patent Office: 1,468 Days
• Field of Search: 607/9, 607/17
• US Class Current: 607/9
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence

Abstract

An improved pacemaker has a hysteresis feature that activates accelerated pacing during periods of sinus arrest and/or extreme bradycardia. When the patient'"'"'s intrinsic heart rate drops below a hysteresis rate, the pacemaker reverts to a programmable accelerated rate or to the average cardiac rate. Accelerated pacing is delivered for a programmable period of time, after which the pacing rate is gradually reduced toward a lower rate. If a desirable intrinsic rate is not attained after the pacing rate is reduced to the lower rate, the intervention cycle repeats.

Claims

1. An implantable medical device compromising:

a sensing arrangement to sense electrical cardiac signals;

a pulse generator to deliver stimulation pulses to a heart; and

a control arrangement, responsive to the sensing arrangement, to respond to an intrinsic heart rate decreasing below a first hysteresis rate by directing the pulse generator to deliver stimulation pulses at an accelerated rate greater than a programmed lower rate for a programmed duration, decreasing the rate of delivery after the proqrammed duration, and directing the pulse generator to deliver additional stimulation pulses at the accelerated rate if the intrinsic heart rate does not increase to a level at or above the first rate, wherein the control arrangement is further configured to select the accelerated rate as the greater of a fixed rate and art average heart rate over a period immediately before decrease of the intrinsic heart rate below the hysteresis rate.

2. The implantable medical device of claim 1, wherein the control arrangement is further configured to direct the pulse generator to repeat delivering additional stimulation pulses at the accelerated rate and decreasing the rate of delivery until the intrinsic heart rate increases to a level at or above the hysteresis rate.

3. The implantable medical device of claim 1, wherein the accelerated rate is programmed to a fixed rate greater than the programmed lower rate.

4. The implantable medical device of claim 1, wherein the accelerated rate is an average heart rate over a period immediately before decrease of the intrinsic heart rate below the hysteresis rate.

5. The implantable medical device of claim 1, wherein the control arrangement is further configured to decrease the rate of delivery of the stimulation pulses toward the programmed lower rate at a programmed rate of deceleration.

6. The implantable medical device of claim 1, wherein the control arrangement is further configured to determine the programmed rate of deceleration as a function of a percentage of a difference between the accelerated rate and the programmed lower rate.

7. The implantable medical device of claim 1, wherein the control arrangement is further configured to direct the pulse generator to cease delivery of stimulation pulses when the intrinsic heart rate returns to a normal rate.

8. The implantable medical device of claim 1, wherein the control arrangement is further configured to direct the pulse generator to cease delivery of stimulation pulses when a ventricular rhythm exceeds the rate of delivery of stimulation pulses.

9. The implantable medical device of claim 1, wherein the implantable medical device is a single-chamber cardiac pacemaker configured to operate in at least one of the group of modes consisting of AAI, AAIR, VVI, VVIR, VVI-ICD, and VVIR-ICD operational modes.

10. The implantable medical device of claim 1, wherein the implantable medical device is a dual-chamber cardiac pacemaker configured to operate in at least one of the group of modes consisting of AAI, AAIR, VVI, VVIR, DDD, DDDR, VVI-ICD, VVIR-ICD,DDD-ICD, and DDDR-ICD operational modes.

11. The implantable medical device of claim 1, further comprising means for repeating delivering additional stimulation pulses at the accelerated rate and decreasing the rate of delivery until the intrinsic heart rate increases to a level at or above the hysteresis rate.

12. The implantable medical device of claim 1, further comprising means for programming the implantable medical device.

13. An implantable medical device system comprising:

a sensing arrangement to sense electrical cardiac signals;

a pulse generator to deliver stimulation pulses to a heart;

at least one pacing lead, coupled to the pulse generator and configured to deliver the stimulation pulses to a chamber of the heart; and

a control arrangement responsive to the sensing arrangement and configured to respond to an intrinsic heart rate decreasing below a hysteresis rate by directing the pulse generator to deliver stimulation pulses to the heart at an accelerated rate greater than a programmed lower rate for a programmed duration, decreasing the rate of delivery after the programmed duration, and repeating directing the pulse generator to deliver stimulation pulses at the accelerated rate unless the intrinsic heart rate is recovered, wherein the control arrangement is further configured to select the accelerated rate as the greater of a fixed rate and an average heart rate over a period immediately before decrease of the intrinsic heart rate below the hysteresis rate.

14. The implantable medical device system of claim 13, wherein the accelerated rate is programmed to a fixed rate greater than the programmed lower rate.

15. The implantable medical device system of claim 13, wherein the accelerated rate is an average heart rate over a period immediately before decrease of the intrinsic heart rate below the hysteresis rate.

16. The implantable medical device system of claim 13, wherein the control arrangement is further configured to decrease the rate of delivery toward the programmed lower rate at a programmed rate of deceleration.

17. The implantable medical device system of claim 16, wherein the control arrangement is further configured to determine the programmed rate of deceleration as a function of a percentage of a difference between the accelerated rate and the programmed lower rate.

18. The implantable medical device system of claim 13, wherein the control arrangement is further configured to direct the pulse generator to cease delivery of stimulation pulses when the intrinsic heart rate returns to a normal rate.

19. The implantable medical device system of claim 13, wherein the control arrangement is further configured to direct the pulse generator to cease delivery of stimulation pulses when a ventricular rhythm exceeds the rate of delivery of stimulation pulses.

20. The implantable medical device system of claim 13, wherein the implantable medical device system comprises a single-chamber cardiac pacemaker configured to operate in at least one of the group of modes consisting of AAI, AAIR, VVI, VVIR, VVI-ICD, and VVIR-ICD operational modes.

21. The implantable medical device system of claim 13, wherein the implantable medical device system comprises a dual-chamber cardiac pacemaker configured to operate in at least one of the group of modes consisting of AAI, AAIR, VVI, VVIR, DDD, DDDR, VVI-ICD, VVIR-ICD, DDD-ICD, and DDDR-ICD operational modes.

22. The implantable medical device system of claim 13, further comprising a programming arrangement to program the control arrangement.

23. The implantable medical device system of claim 22, wherein the programming arrangement comprises a microprocessor to provide an encoded signal to the control arrangement.

24. A method of cardiac pacing comprising:

detecting an intrinsic heart rate;

when the intrinsic heart rate decreases below a hysteresis rate, delivering stimulation pulses to a heart at an accelerated rate greater than a programmed lower rate for a programmed duration;

decreasing the rate of delivery after the programmed duration; and

repeating delivering stimulation pulses at the accelerated rate unless the intrinsic heart rate is recovered, further comprising selecting the accelerated rate as the greater of a fixed rate and an average heart rate over a period immediately before decrease of the intrinsic heart rate below the hysteresis rate.

25. The method of cardiac pacing of claim 24, wherein the accelerated rate is programmed to a fixed rate greater than the programmed lower rate.

26. The method of cardiac pacing of claim 24, wherein the accelerated rate is an average heart rate over a period immediately before decrease of the intrinsic heart rate below the hysteresis rate.

27. The method of cardiac pacing of claim 24, further comprising decreasing the rate of delivery toward the programmed lower rate at a programmed rate of deceleration.

28. The method of cardiac pacing of claim 27, further comprising determining the programmed rate of deceleration as a function of a percentage of a difference between the accelerated rate and the programmed lower rate.

29. The method of cardiac pacing of claim 24, further comprising ceasing delivery of stimulation pulses when the intrinsic heart rate returns to a normal rate.

30. The method of cardiac pacing of claim 24, further comprising ceasing delivery of stimulation pulses when a ventricular rhythm exceeds the rate of delivery of stimulation pulses.

31. A method of cardiac pacing comprising:

defining a hysteresis rate lower than a programmed lower rate and an accelerated rate greater than the programmed lower rate;

when an intrinsic heart rate decreases below the hysteresis rate, delivering stimulation pulses to a heart at the accelerated rate for a programmed duration;

decreasing the rate of delivery after the programmed duration at a programmed rate of deceleration; and

ceasing delivery of stimulation pulses when the intrinsic heart rate returns to a normal rate, further comprising selecting the accelerated rate as the greater of a fixed rate and an average heart rate over a period immediately before decrease of the intrinsic heart rate below the hysteresis rate.

32. A method of manufacturing an implantable medical device comprising:

providing a sensing arrangement to sense electrical cardiac signals;

providing a pulse generator to deliver stimulation pulses to a heart;

coupling a control arrangement to the sensing arrangement; and

programming the control arrangement to respond to an intrinsic heart rate decreasing below a hysteresis rate by directing the pulse generator to deliver stimulation pulses to the heart at an accelerated rate greater than a programmed lower rate for a programmed duration decreasing the rate of delivery after the programmed duration, and repeating directing the pulse generator to deliver stimulation pulses at the accelerated rate unless the intrinsic heart rate is recovered, further comprising programming the control arrangement to select the accelerated rate as the greater of a fixed rate and an average heart rate over a period immediately before decrease of the intrinsic heart rate below the hysteresis rate.

33. The method of manufacturing an implantable medical device of claim 32, further comprising programming the control arrangement to decrease the rate of delivery toward the programmed lower rate at a programmed rate of deceleration.

34. The method of manufacturing an implantable medical device of claim 32, further comprising programming the control arrangement to direct the pulse generator to cease delivery of stimulation pulses when the intrinsic heart rate returns to a normal rate.

35. The method of manufacturing an implantable medical device of claim 32, further comprising programming the control arrangement to direct the pulse generator to cease delivery of stimulation pulses when a ventricular rhythm exceeds the rate of delivery of stimulation pulses.

36. The method of manufacturing an implantable medical device of claim 32, further comprising configuring the implantable medical device to operate in at least one of the group of modes consisting of AAI, AAIR, VVI, VVIR, DDD, DDDR, VVI-ICD, VVIR-ICD, DDD-ICD, and DDDR-ICD operational modes.